Trial intelligence / Profile preview

Remimazolam vs propofol anesthesia for postoperative delirium in older adults after oral tumor surgery

ChiCTR2200065213Phase 4Not yet recruiting

Sponsor
First Affiliated Hospital of Soochow University
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of remimazolam in postoperative delirium (POD) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Incidence of postoperative delirium. Planned start Nov 2022; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2200065213.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200065213.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call